IMNMNasdaq United States
Market cap
$2.835 B
$25.03 -3.06%
Close of 7 Aug 2026
Revenue
$6.94M
#3241 by revenue
Earnings
-$212.4M
Loss-making
Shares outstanding
113,133,199
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Immunome are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.